NCT06105047

Brief Summary

Memories are more robust when they are multitraced. This means that the more a piece of information is mediated by different sensory inputs, the more resistant it is to being forgotten. Many works in the field of embodied cognition show that new learnings are better recalled over the long term when they are learned during body mobilization. Other works show that musical stimulation could be a good way of eliciting physiological and emotional states more favorable to the memorization of new contents. However, to date, no studies have examined the positive effects of these two tools combined in Alzheimer's disease. The investigators suggest that it is possible to optimize memory in Alzheimer's disease by referring to their motor and emotional resources. The hypothesis is that information will be better recalled with multimodal enriched learning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 22, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2025

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2025

Completed
Last Updated

June 25, 2025

Status Verified

June 1, 2025

Enrollment Period

1.3 years

First QC Date

October 23, 2023

Last Update Submit

June 19, 2025

Conditions

Keywords

AlzheimerAction memoryMusical memory

Outcome Measures

Primary Outcomes (1)

  • "Discrimination score"

    Comparison of the recognition score obtained in each of the experimental conditions to the recognition score obtained in the control condition The score = the Number of correct answer (0 to 15, the higher score means better outcome)

    Weeks: 2

Secondary Outcomes (1)

  • "Geneva Music-Induced Affect Checklist" scale

    Weeks: 2

Study Arms (1)

Patients with Alzheimer disease

EXPERIMENTAL

Patients will perform experimental task in four conditions : control, mime, emotion, dual

Behavioral: Cognitive tests

Interventions

Cognitive testsBEHAVIORAL

. Patients will perform experimental task in four conditions : control, mime, emotion, dual In a control condition : they will be asked to read the sentence aloud; in a motor-only condition, they will also be asked to mime the sentence; in an emotional-only condition, they will be asked to read the sentence while listening to music; in a dual condition, they will be asked to both mime and listen to music. Immediately after each condition, they will realize a recognition task * quiz : Geneva Music Induced Checklist, GMIAC, Coutinho \& Scherer, 2017

Patients with Alzheimer disease

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Alzheimer's disease by one of the consulting physicians, neurologist and/or geriatrician of whom the patient has been informed.
  • Early stage (MMSE ≥ 22)
  • Affiliation with a social security scheme
  • Age equal to or greater than 60
  • French mother tongue
  • Agreement to participate / signature of consent form

You may not qualify if:

  • Uncorrected perceptual disorders
  • Other neurological or psychiatric history
  • Inability to communicate
  • Delusional or psychotic state
  • Person unable to give informed consent
  • Refusal to participate
  • Participation in a study on a drug/medical device/care technique likely to affect cognitive functions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

CHU Grenoble

Grenoble, France

Location

CHU de Saint-Etienne

Saint-Etienne, 42055, France

Location

HCL

Villeurbanne, France

Location

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Céline BORG, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2023

First Posted

October 27, 2023

Study Start

January 22, 2024

Primary Completion

May 9, 2025

Study Completion

May 16, 2025

Last Updated

June 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations